This article is from WeChat public account: Month Apollo (ID: gh_de6424661304) , author: spy Apollo, the original title: “The most miserable day! I still have to step on the best-performing plate today “, the picture from: Visual China

The first trading day after the Spring Festival, it turned out to be a storm:

Shanghai Stock Index fell by 7.72%

SZSE Component Index fell 8.45%

GEM index fell by 6.85%

I simply calculated the historical data. Today, the Shanghai Stock Exchange Index fell 5th in the 20 years in 2000, and it was even worse than when it broke in 16 years.

It is even more exaggerated that today, 1315 stocks out of 1,543 stocks in the Shanghai Stock Exchange suffered a severe limit, with a limit of 85%, the worst in history. This is even more fierce than in the 2008 and 15 stock disasters.

It can be said that today is the day when most people lose most money since 2000.

In addition, from the table above, we can also see that the short-term performance after the super-trend day is up or down, and there is no regularity.

After the crash, I hurriedly desperateWant to rebound in the broader market, do not worry.

What will happen in the short term depends on the development of the epidemic.

Looking at the latest data released by the National Health and Medical Commission this morning, we will find that there were two indicators that appeared to have an inflection point yesterday. One was newly suspected, and the other was newly confirmed diagnosis outside Hubei. There has been a rebound today, and the situation is still not optimistic.

Looking at specific cases, we can find cases of community transmission in Hubei Province, such as Shenzhen, where there is no clear history of contact. A takeaway brother does not know when and where he was infected with the virus.

If you don’t think the above is a thing, then I suggest you go to Weibo to check out Chaos # pulmonitis patients seeking help #. The current medical resources are still a very, very big problem.

The epidemic is still under development and must not be taken lightly.

After speaking the bad news, let’s talk about the good news.

Although we don’t know when the epidemic will improve, the stock market will pick up. But we can at least roughly perceive the current position from the market valuation.

The current valuation of the CSI 300 is 11.2 times, only 10% higher than its 18-year low.

Do you think the situation is better or worse now than it was at the end of deleveraging at the end of 18 years and being challenged by trade conflicts?

Overall, I think it’s better now.

We know exactly what kind of investment opportunities the end of 18 represents.

So, although we don’t know if the market will fall, we should be very clear now that it is a good buying point in the long run.

Actually, in investing, we want to make money without having to guess when it is the lowest point.

As long as you canWhen the ticket has the right buying opportunity, buy it boldly, and that’s it.

Generally speaking, all the high-quality assets in the entire market, whether it is technology stocks or consumer stocks, now have some good opportunities after a day of plunge.

There is only one sector, and I think we need to be especially careful, that is, the best pharmaceutical stocks that have risen today.

Most of the stocks that rose today are pharmaceutical stocks.

The basic reason I actually said it again yesterday, and today I say it again: Not only many of the so-called pharmaceutical beneficiary stocks are one-time short-term benefits that do not have continuity, but many are still very, very general bad stocks. This emotional Conceptual hype will not last.

How much will it rise in the short term, how much debt will be repaid in the later period.

In SARS before, exactly the same thing happened. Pharmaceutical stocks thrived when the entire market was sluggish.

However, after a short period of hype, pharmaceutical stocks underperformed the index in the second half of the year.

Most pharmaceutical companies are not doing well when the epidemic comes. Logic I said yesterday, and today I will talk about historical facts. Xinhua Medicine and Hengrui Medicine issued announcements during the SARS period.

Xinhua Medicine: Although the sales of SARS-related drugs increased during the SARS period, the number of hospitalized patients decreased and the amount of clinical medications dropped significantly.

Hengrui Medicine: National outbreak of atypical pneumonia in hospitalsThe decrease in drug consumption has led to a certain negative impact on the company’s sales increase.

With the advent of the epidemic, only a few companies, such as related equipment, drugs, pharmacies, and Internet healthcare, are really good. And the hype brought by the epidemic will be very, very short. Good track and performance are the long-term logic for investing in pharmaceutical stocks.

Unlike other industries, the investment direction of the entire investment circle for pharmaceutical stocks is surprisingly consistent. The pharmaceutical sector is very differentiated. Stocks on the good track are quite expensive, while other pharmaceutical stocks are quite different. Wait to be seen.

To tell you briefly, if you want to buy pharmaceutical stocks, which ones can be considered.

The investment direction of pharmaceutical stocks today is based on innovation.

In addition to innovative drugs, there are innovative medical devices, innovative medical services, and innovative medical consumer products. The unified logic in these areas is that demand is constantly rising and at the same time, it is less suppressed by medical insurance policies.

In 2019, high-quality leaders in these innovative segments have performed strongly, and their stock prices have hit record highs. Research and excavation of these companies with continuous growth is the focus of current pharmaceutical investment.

I counted the 2020 portfolio of 20 brokerage companies in the pharmaceutical industry, and you will find that they are concentrated in the above-mentioned directions without exception:

The above table basically represents the best pharmaceutical stocks in the entire A-share market, but it is currently not cheap.

Among them, several companies in the CRO industry that provide innovative drug research and development services are the most promising, followed by vaccine companies.

This article is from the WeChat public account: Apollo, the Moon ’s agent (ID: gh_de6424661304) , author: spy Apollo